631 related articles for article (PubMed ID: 19863443)
1. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
2. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
[TBL] [Abstract][Full Text] [Related]
3. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
Escher F; Modrow S; Sabi T; Kühl U; Lassner D; Schultheiss HP; Noutsias M
Med Sci Monit; 2008 Dec; 14(12):CR589-97. PubMed ID: 19043365
[TBL] [Abstract][Full Text] [Related]
4. Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy.
Ruppert V; Meyer T; Balbach A; Richter A; Müller HH; Maisch B; Pankuweit S;
J Med Virol; 2011 Oct; 83(10):1818-25. PubMed ID: 21837800
[TBL] [Abstract][Full Text] [Related]
5. No detection of human bocavirus in amniotic fluid samples from fetuses with hydrops or isolated effusions.
Enders M; Lindner J; Wenzel JJ; Baisch C; Schalasta G; Enders G; Modrow S
J Clin Virol; 2009 Aug; 45(4):300-3. PubMed ID: 19473872
[TBL] [Abstract][Full Text] [Related]
6. Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury.
Lotze U; Egerer R; Glück B; Zell R; Sigusch H; Erhardt C; Heim A; Kandolf R; Bock T; Wutzler P; Figulla HR
J Med Virol; 2010 Aug; 82(8):1449-57. PubMed ID: 20572082
[TBL] [Abstract][Full Text] [Related]
7. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons.
Corcioli F; Zakrzewska K; Rinieri A; Fanci R; Innocenti M; Civinini R; De Giorgi V; Di Lollo S; Azzi A
J Med Virol; 2008 Nov; 80(11):2005-11. PubMed ID: 18814251
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical aspects of human bocavirus infection in children.
Karalar L; Lindner J; Schimanski S; Kertai M; Segerer H; Modrow S
Clin Microbiol Infect; 2010 Jun; 16(6):633-9. PubMed ID: 19681960
[TBL] [Abstract][Full Text] [Related]
9. Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients.
Escher F; Kuhl U; Sabi T; Suckau L; Lassner D; Poller W; Schultheiss HP; Noutsias M
Med Sci Monit; 2008 Jun; 14(6):CR333-338. PubMed ID: 18509278
[TBL] [Abstract][Full Text] [Related]
10. Absence of human bocavirus from deceased fetuses and their mothers.
Riipinen A; Väisänen E; Lahtinen A; Karikoski R; Nuutila M; Surcel HM; Taskinen H; Hedman K; Söderlund-Venermo M
J Clin Virol; 2010 Feb; 47(2):186-8. PubMed ID: 20031484
[TBL] [Abstract][Full Text] [Related]
11. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
Koppelman MH; Rood IG; Fryer JF; Baylis SA; Cuypers HT
Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
[TBL] [Abstract][Full Text] [Related]
13. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
16. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
Cassinotti P; Siegl G; Michel BA; Brühlmann P
J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
18. The detection of parvoviruses.
Doyle S
Methods Mol Biol; 2011; 665():213-31. PubMed ID: 21116804
[TBL] [Abstract][Full Text] [Related]
19. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.
Plentz A; Würdinger M; Kudlich M; Modrow S
J Clin Virol; 2013 Oct; 58(2):443-8. PubMed ID: 23916377
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization.
Wang X; Zhang G; Liu F; Han M; Xu D; Zang Y
J Clin Virol; 2004 Sep; 31(1):20-4. PubMed ID: 15288609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
